Metropolis Healthcare PAT at Rs 58.26 cr in Q2FY22
Metropolis Healthcare has reported consolidated financial results for the period ended September 30, 2021
Metropolis Healthcare has reported consolidated financial results for the period ended September 30, 2021
The revised deal involves a cash consideration only as against the earlier proposal of cash and equity
The lab will offer over 4,000 clinical tests and profiles and can conduct over 20,000 sample tests per month.
The lab will offer about 4,000 different tests ranging from basic to high-end molecular diagnostic tests
Board approves fundraise of Rs 1500 crore
In the interim, the statutory approvals obtained by the company under SEBI ICDR have lapsed in accordance with applicable law and are required to be re-obtained
Dr Kinha is a seasoned healthcare and diagnostics leader with over 17 years of experience across leading organisations in the diagnostics sector, with deep expertise in laboratory operations and quality systems
New leadership team announced at NATHEALTH Annual General Meeting 2024
Launched in the year 2018, MedEngage Scholarship Program is aimed at nurturing and nourishing medical talent in India
Subscribe To Our Newsletter & Stay Updated